270 related articles for article (PubMed ID: 16138249)
21. A case of Canavan disease with microcephaly.
Gowda VK; Bhat MD; Srinivasan VM; Prasad C; Benakappa A; Faruq M
Brain Dev; 2016 Sep; 38(8):759-62. PubMed ID: 26992473
[TBL] [Abstract][Full Text] [Related]
22. A missense mutation (p.G274R) in gene ASPA causes Canavan disease in a Pakistani family.
Hussain R; Daud S; Kakar N; Ahmad A; Baloch AH; Tareen AM; Kakar MA; Ahmad J
Mol Biol Rep; 2012 May; 39(5):6197-201. PubMed ID: 22219087
[TBL] [Abstract][Full Text] [Related]
23. A benign polymorphism in the aspartoacylase gene may cause misinterpretation of Canavan gene testing.
Propheta O; Magal N; Shohat M; Eyal N; Navot N; Horowitz M
Eur J Hum Genet; 1998; 6(6):635-7. PubMed ID: 9887384
[TBL] [Abstract][Full Text] [Related]
24. Mutation analysis of the aspartoacylase gene in non-Jewish patients with Canavan disease.
Zeng BJ; Pastores GM; Leone P; Raghavan S; Wang ZH; Ribeiro LA; Torres P; Ong E; Kolodny EH
Adv Exp Med Biol; 2006; 576():165-73; discussion 361-3. PubMed ID: 16802711
[No Abstract] [Full Text] [Related]
25. Identification and characterization of novel mutations of the aspartoacylase gene in non-Jewish patients with Canavan disease.
Zeng BJ; Wang ZH; Ribeiro LA; Leone P; De Gasperi R; Kim SJ; Raghavan S; Ong E; Pastores GM; Kolodny EH
J Inherit Metab Dis; 2002 Nov; 25(7):557-70. PubMed ID: 12638939
[TBL] [Abstract][Full Text] [Related]
26. Atypical clinical and radiological course of a patient with Canavan disease.
Sarret C; Boespflug-Tanguy O; Rodriguez D
Metab Brain Dis; 2016 Apr; 31(2):475-9. PubMed ID: 26586007
[TBL] [Abstract][Full Text] [Related]
27. Expression of aspartoacylase (ASPA) and Canavan disease.
Sommer A; Sass JO
Gene; 2012 Sep; 505(2):206-10. PubMed ID: 22750302
[TBL] [Abstract][Full Text] [Related]
28. Canavan disease: a white matter disorder.
Kumar S; Mattan NS; de Vellis J
Ment Retard Dev Disabil Res Rev; 2006; 12(2):157-65. PubMed ID: 16807907
[TBL] [Abstract][Full Text] [Related]
29. An atypical case of Canavan disease with stroke-like presentation.
Delaney KE; Kralik SF; Hainline BE; Golomb MR
Pediatr Neurol; 2015 Feb; 52(2):218-21. PubMed ID: 25497124
[TBL] [Abstract][Full Text] [Related]
30. Novel mutation in an Egyptian patient with infantile Canavan disease.
Zaki OK; El Abd HS; Mohamed SA; Zayed H
Metab Brain Dis; 2016 Jun; 31(3):573-7. PubMed ID: 26613958
[TBL] [Abstract][Full Text] [Related]
31. Homozygosity for mutation G212A of the gene for aspartoacylase is associated with atypical form of Canavan's disease.
Velinov M; Zellers N; Styles J; Wisniewski K
Clin Genet; 2008 Mar; 73(3):288-9. PubMed ID: 18070137
[No Abstract] [Full Text] [Related]
32. Clinical protocol. Gene therapy of Canavan disease: AAV-2 vector for neurosurgical delivery of aspartoacylase gene (ASPA) to the human brain.
Janson C; McPhee S; Bilaniuk L; Haselgrove J; Testaiuti M; Freese A; Wang DJ; Shera D; Hurh P; Rupin J; Saslow E; Goldfarb O; Goldberg M; Larijani G; Sharrar W; Liouterman L; Camp A; Kolodny E; Samulski J; Leone P
Hum Gene Ther; 2002 Jul; 13(11):1391-412. PubMed ID: 12162821
[TBL] [Abstract][Full Text] [Related]
33. Protracted course of N-acetylaspartic aciduria in two non-Jewish siblings: identical clinical and magnetic resonance imaging findings.
Zafeiriou DI; Kleijer WJ; Maroupoulos G; Anastasiou AL; Augoustidou-Savvopoulou P; Papadopoulou F; Kontopoulos EE; Fagan E; Payne S
Brain Dev; 1999 Apr; 21(3):205-8. PubMed ID: 10372908
[TBL] [Abstract][Full Text] [Related]
34. [Genotype and phenotype of gastrointestinal symptoms analysis in children with cystic fibrosis].
Iwańczak F; Smigiel R; Stawarski A; Pawłowicz J; Stembalska A; Mowszet K; Sasiadek M
Pol Merkur Lekarski; 2005 Feb; 18(104):205-9. PubMed ID: 17877132
[TBL] [Abstract][Full Text] [Related]
35. [Canavan disease (aspartoacylase deficiency)].
Kobayashi K; Sakuragawa N
Ryoikibetsu Shokogun Shirizu; 1998; (18 Pt 1):385-8. PubMed ID: 9590077
[No Abstract] [Full Text] [Related]
36. Preimplantation genetic diagnosis of Canavan disease.
Yaron Y; Schwartz T; Mey-Raz N; Amit A; Lessing JB; Malcov M
Fetal Diagn Ther; 2005; 20(5):465-8. PubMed ID: 16113575
[TBL] [Abstract][Full Text] [Related]
37. N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase.
Francis JS; Wojtas I; Markov V; Gray SJ; McCown TJ; Samulski RJ; Bilaniuk LT; Wang DJ; De Vivo DC; Janson CG; Leone P
Neurobiol Dis; 2016 Dec; 96():323-334. PubMed ID: 27717881
[TBL] [Abstract][Full Text] [Related]
38. Identification and expression of eight novel mutations among non-Jewish patients with Canavan disease.
Kaul R; Gao GP; Matalon R; Aloya M; Su Q; Jin M; Johnson AB; Schutgens RB; Clarke JT
Am J Hum Genet; 1996 Jul; 59(1):95-102. PubMed ID: 8659549
[TBL] [Abstract][Full Text] [Related]
39. Two novel aspartoacylase gene (ASPA) missense mutations specific to Norwegian and Swedish patients with Canavan disease.
Olsen TR; Tranebjaerg L; Kvittingen EA; Hagenfeldt L; Møller C; Nilssen O
J Med Genet; 2002 Sep; 39(9):e55. PubMed ID: 12205125
[No Abstract] [Full Text] [Related]
40. Upregulation of N-acetylaspartic acid resulting nitric oxide toxicity induces aspartoacylase mutations and protein interaction to cause pathophysiology seen in Canavan disease.
Surendran S
Med Hypotheses; 2010 Dec; 75(6):533-4. PubMed ID: 20673702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
